Table 3.
Characteristics of low and high CRP groups for fatty acid intakes
| Low CRP (n 453) | High CRP (n 364) | P-value* | |||
|---|---|---|---|---|---|
| Mean/n | 95 % CI/% | Mean/n | 95 % CI/% | ||
| Sex (female), n | 266 | 58⋅72 | 165 | 45⋅33 | <0⋅001 |
| Age, years | 62⋅71 | 61⋅72, 63⋅70 | 65⋅06 | 64⋅05, 66⋅06 | 0⋅001 |
| Lack of exercise, n | 352 | 77⋅70 | 296 | 81⋅32 | 0⋅202 |
| Lack of sleep, n | 318 | 70⋅20 | 278 | 76⋅37 | 0⋅047 |
| Current smoker, n | 68 | 15⋅01 | 80 | 21⋅98 | 0⋅012 |
| Current drinker, n | 210 | 46⋅36 | 174 | 47⋅80 | 0⋅681 |
| BMI, kg/m2 | 22⋅51 | 22⋅24, 22⋅77 | 24⋅21 | 23⋅87, 24⋅56 | <0⋅001 |
| Diabetes treatment, n | 39 | 8⋅61 | 26 | 7⋅14 | 0⋅442 |
| Dyslipidemia treatment, n | 46 | 10⋅15 | 40 | 10⋅99 | 0⋅700 |
| Neck/shoulder/upper limb pain, n | 19 | 4⋅19 | 16 | 4⋅40 | 0⋅888 |
| CRP, mg/dl | 0⋅03 | 0⋅03, 0⋅03 | 0⋅27 | 0⋅19, 0⋅35 | <0⋅001 |
| SFA, % energy | 6⋅48 | 6⋅31, 6⋅65 | 6⋅31 | 6⋅10, 6⋅52 | 0⋅207 |
| MUFA, % energy | 8⋅75 | 8⋅53, 8⋅97 | 8⋅44 | 8⋅20, 8⋅68 | 0⋅064 |
| PUFA, % energy | 6⋅15 | 6⋅00, 6⋅29 | 5⋅98 | 5⋅82, 6⋅13 | 0⋅113 |
| n-3 fatty acids, % energy | 1⋅34 | 1⋅30, 1⋅38 | 1⋅33 | 1⋅28, 1⋅37 | 0⋅719 |
| n-6 fatty acids, % energy | 4⋅79 | 4⋅67, 4⋅90 | 4⋅63 | 4⋅50, 4⋅75 | 0⋅066 |
| C18:1(M), mg/1000 kcal | 8660⋅12 | 8437⋅88, 8882⋅36 | 8329⋅08 | 8080⋅96, 8577⋅19 | 0⋅052 |
| C18:2(n6)(P(n-6)), mg/1000 kcal | 5159⋅31 | 5033⋅43, 5285⋅19 | 4982⋅19 | 4845⋅31, 5119⋅07 | 0⋅063 |
| C18:3(n3)(P(n-3)), mg/1000 kcal | 832⋅46 | 808⋅68, 856⋅24 | 799⋅71 | 775⋅01, 824⋅40 | 0⋅064 |
| C20:2(n6)(P(n-6)), mg/1000 kcal | 24⋅18 | 23⋅40, 24⋅95 | 23⋅38 | 22⋅49, 24⋅26 | 0⋅182 |
Abbreviations: CI, confidence interval; BMI, body mass index; CRP, C-reactive protein; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
P-values were calculated using the Student's t test and χ2 test for continuous and categorical variables, respectively (P-values < 0⋅05 are highlighted in bold).